SCHEMBL9924254

SCHEMBL9924254

CCOC(=O)NC1CCC(N/C(=N\C(=O)c2ccc(C)c(F)c2)Nc2cc(F)cc(Cl)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.39
KCNQ3 O43525 2/20 0.35
KCNQ2 O43526 2/20 0.35
KCNE1 P15382 2/20 0.35
KCNQ1 P51787 2/20 0.35
GRM4 Q14833 1/20 0.34
KCNQ5 Q9NR82 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
EPHX2 P34913 1/20 0.34
CHRM3 P20309 6/20 0.34
AR P10275 1/20 0.34
MC5R P33032 1/20 0.34
POLB P06746 1/20 0.33
MCHR1 Q99705 1/20 0.33
HSD11B1 P28845 1/20 0.33
XPO1 O14980 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17206702 0.95 CHRM1 (0.38) CHRM1GRM4ALDH1A1MEN1KMT2A
SCHEMBL9924259 0.95 CHRM1 (0.38) CHRM1GRM4ALDH1A1MEN1KMT2A
SCHEMBL9924228 0.95 CHRM1 (0.38) CHRM1GRM4ALDH1A1MEN1KMT2A
SCHEMBL9924084 0.94 GRM4 (0.35) GRM4ALDH1A1MEN1KMT2AEPHX2
SCHEMBL9924087 0.91 HSD11B1 (0.39) GRM4ALDH1A1MEN1KMT2AEPHX2
SCHEMBL9924255 0.90 GRM4 (0.36) GRM4ALDH1A1MEN1KMT2AEPHX2
SCHEMBL9924077 0.89 GRM4 (0.38) GRM4ALDH1A1KMT2AEPHX2CHRM3
SCHEMBL9923892 0.88 MAPT (0.40) GRM4MC5RHSD11B1
SCHEMBL9924080 0.88 MAPT (0.40) GRM4MC5RHSD11B1
SCHEMBL9924082 0.88 CHRM1 (0.38) CHRM1GRM4MEN1KMT2AMC5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed